These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 28492454)
21. Valproate or olanzapine add-on to lithium: an 8-week, randomized, open-label study in Italian patients with a manic relapse. Maina G; Albert U; Salvi V; Mancini M; Bogetto F J Affect Disord; 2007 Apr; 99(1-3):247-51. PubMed ID: 17056122 [TBL] [Abstract][Full Text] [Related]
22. The effectiveness of divalproate in all forms of mania and the broader bipolar spectrum: many questions, few answers. Bowden C J Affect Disord; 2004 Apr; 79 Suppl 1():S9-14. PubMed ID: 15121342 [TBL] [Abstract][Full Text] [Related]
23. Treatment of Early-Age Mania: Outcomes for Partial and Nonresponders to Initial Treatment. Walkup JT; Wagner KD; Miller L; Yenokyan G; Luby JL; Joshi PT; Axelson DA; Robb A; Salpekar JA; Wolf D; Sanyal A; Birmaher B; Vitiello B; Riddle MA J Am Acad Child Adolesc Psychiatry; 2015 Dec; 54(12):1008-19. PubMed ID: 26598476 [TBL] [Abstract][Full Text] [Related]
24. One-year rehospitalization rates of patients with first-episode bipolar mania receiving lithium or valproate and adjunctive atypical antipsychotics. Woo YS; Bahk WM; Jung YE; Jeong JH; Lee HB; Won SH; Lee KH; Jon DI; Yoon BH; Kim MD; Min KJ Psychiatry Clin Neurosci; 2014 Jun; 68(6):418-24. PubMed ID: 24506520 [TBL] [Abstract][Full Text] [Related]
25. Relationship of lithium chloride dose to treatment response in acute mania. Stokes PE; Kocsis JH; Arcuni OJ Arch Gen Psychiatry; 1976 Sep; 33(9):1080-4. PubMed ID: 17642108 [TBL] [Abstract][Full Text] [Related]
26. Lithium neurotoxicity at low therapeutic doses Hypotheses for causes and mechanism of action following a retrospective analysis of published case reports. Emilien G; Maloteaux JM Acta Neurol Belg; 1996 Dec; 96(4):281-93. PubMed ID: 9008777 [TBL] [Abstract][Full Text] [Related]
27. [Predictors of prophylactic response to lithium]. Rohayem J; Baylé JF; Richa S Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242 [TBL] [Abstract][Full Text] [Related]
28. Efficacy of olanzapine combined with valproate or lithium in the treatment of dysphoric mania. Baker RW; Brown E; Akiskal HS; Calabrese JR; Ketter TA; Schuh LM; Trzepacz PT; Watkin JG; Tohen M Br J Psychiatry; 2004 Dec; 185():472-8. PubMed ID: 15572737 [TBL] [Abstract][Full Text] [Related]
29. Mood-dependent changes of serum lithium concentration in a rapid cycling patient maintained on stable doses of lithium carbonate. Rittmannsberger H; Malsiner-Walli G Bipolar Disord; 2013 May; 15(3):333-7. PubMed ID: 23521652 [TBL] [Abstract][Full Text] [Related]
30. Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial. Niufan G; Tohen M; Qiuqing A; Fude Y; Pope E; McElroy H; Ming L; Gaohua W; Xinbao Z; Huichun L; Liang S J Affect Disord; 2008 Jan; 105(1-3):101-8. PubMed ID: 17531327 [TBL] [Abstract][Full Text] [Related]
31. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania. Sussman N; Mullen J; Paulsson B; Vågerö M J Affect Disord; 2007; 100 Suppl 1():S55-63. PubMed ID: 17383736 [TBL] [Abstract][Full Text] [Related]
32. Mania in the Nordic countries: patients and treatment in the acute phase of the EMBLEM study. Larsen JK; Porsdal V; Aarre TF; Koponen HJ; Aarnio J; Kleivenes OK; Nord J Psychiatry; 2009; 63(4):285-91. PubMed ID: 19140076 [TBL] [Abstract][Full Text] [Related]
33. Use of antipsychotic drugs and lithium in mania. Cookson J Br J Psychiatry Suppl; 2001 Jun; 41():s148-56. PubMed ID: 11450176 [TBL] [Abstract][Full Text] [Related]
35. Pathologic assessment of cerebellar atrophy following acute lithium intoxication. Mangano WE; Montine TJ; Hulette CM Clin Neuropathol; 1997; 16(1):30-3. PubMed ID: 9020392 [TBL] [Abstract][Full Text] [Related]
36. Prescribing patterns of lithium or lithium+valproate in manic or mixed episodes: a naturalistic study. Muti M; Del Grande C; Musetti L; Marazziti D; Pergentini I; Corsi M; Turri M; Umberto Corsini G; Dell'Osso L Int Clin Psychopharmacol; 2013 Nov; 28(6):305-11. PubMed ID: 23873290 [TBL] [Abstract][Full Text] [Related]
37. [Long-term lithium prophylaxis in the bipolar affective disorder]. Suwalska A; Chłopocka-Woźniak M; Rybakowski J Psychiatr Pol; 2002; 36(6 Suppl):63-9. PubMed ID: 12647423 [TBL] [Abstract][Full Text] [Related]
38. Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder. Katagiri H; Takita Y; Tohen M; Higuchi T; Kanba S; Takahashi M Curr Med Res Opin; 2012 May; 28(5):701-13. PubMed ID: 22356118 [TBL] [Abstract][Full Text] [Related]
39. [Pharmacotherapy in bipolar disorder]. Nolen WA Ned Tijdschr Geneeskd; 1999 Jun; 143(25):1299-305. PubMed ID: 10416483 [TBL] [Abstract][Full Text] [Related]
40. Neurotoxicity with therapeutic lithium levels: a case report. Grueneberger EC; Maria Rountree E; Baron Short E; Kahn DA J Psychiatr Pract; 2009 Jan; 15(1):60-3. PubMed ID: 19182567 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]